FDA Approves New Drug Doubling Survival Rate for Pancreatic Cancer Patients
Abu dhabi: The Food and Drug Administration (FDA) has granted approval for a novel oral therapy developed by Revolution Medicines, following late-stage clinical trials showing it can double survival times for individuals with advanced pancreatic cance…